Skip to content
castiglione2

Affiliation

Chiesi Farmaceutici S.p.A.

Country

Italy

1. Current Status, Position

Qualified Person Responsible for Pharmacovigilance and Director at Chiesi Farmaceutici S.p.A.

2. Education

He received his degree in medicine and surgery at the University of Bologna – Italy. After a brief experience as REP at Eli Lilly – Italy, since 1991 he has been working at Chiesi Farmaceutici S.p.A. (Parma – Italy). Initially involved in clinical research projects, since 1997 he is responsible for pharmacovigilance. Currently he serves as Director of Corporate Pharmacovigilance and EU QPPV. Former Professor, he is currently teacher at Masters and speaker in the field of pharmacovigilance. Member of EFPIA Pharmacovigilance Committee, DIA and SSFA.

3. Research Area

Pharmacovigilance. 

Conflict of interest: None

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.